Indegene Ltd (INDGN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.071x

Based on the latest financial reports, Indegene Ltd (INDGN) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.03 Billion ≈ $21.93 Million USD) by net assets (Rs28.66 Billion ≈ $309.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Indegene Ltd (INDGN) market capitalisation for the company's overall valuation and market capitalisation.

Indegene Ltd - Cash Flow Conversion Efficiency Trend (2020–2026)

This chart illustrates how Indegene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Indegene Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indegene Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Indegene Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Top Glove Corporation Bhd
KLSE:7113
0.022x
Kemper Corporation
NYSE:KMPR
-0.012x
SL Corp
KO:005850
0.023x
Permian Basin Royalty Trust
NYSE:PBT
88.414x
Emlak Konut Gayrimenkul Yatirim Ortakligi AS
IS:EKGYO
-0.270x
Central Securities Corporation
NYSE MKT:CET
0.006x
General American Investors Closed Fund
NYSE:GAM
-0.281x
DUERR AG UNSP.ADR 1/5
F:DUEB
0.117x

Annual Cash Flow Conversion Efficiency for Indegene Ltd (2020–2026)

The table below shows the annual cash flow conversion efficiency of Indegene Ltd from 2020 to 2026. View Indegene Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs31.39 Billion
≈ $339.44 Million
Rs6.63 Billion
≈ $71.74 Million
0.211x +25.10%
2025-03-31 Rs26.16 Billion
≈ $282.87 Million
Rs4.42 Billion
≈ $47.79 Million
0.169x -52.44%
2024-03-31 Rs14.29 Billion
≈ $154.55 Million
Rs5.08 Billion
≈ $54.91 Million
0.355x +190.20%
2023-03-31 Rs10.64 Billion
≈ $115.04 Million
Rs1.30 Billion
≈ $14.08 Million
0.122x -68.52%
2022-03-31 Rs7.64 Billion
≈ $82.61 Million
Rs2.97 Billion
≈ $32.12 Million
0.389x -24.71%
2021-03-31 Rs3.33 Billion
≈ $36.02 Million
Rs1.72 Billion
≈ $18.60 Million
0.516x +136.17%
2020-03-31 Rs-155.98 Million
≈ $-1.69 Million
Rs222.73 Million
≈ $2.41 Million
-1.428x --

About Indegene Ltd

NSE:INDGN India Health Information Services
Market Cap
$1.56 Billion
Rs144.21 Billion INR
Market Cap Rank
#7127 Global
#346 in India
Share Price
Rs600.10
Change (1 day)
+1.41%
52-Week Range
Rs423.50 - Rs611.65
All Time High
Rs732.70
About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more